Related Experiment Video
Updated: Jun 16, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[Adverse effects of atazanavir].
R Palacios1, M González, J Ruiz
1Servicio de Medicina Interna, Hospital Virgen de la Victoria, Málaga, España.
Enfermedades Infecciosas Y Microbiologia Clinica
|February 2, 2010
Summary
Atazanavir is an effective HIV protease inhibitor offering once-daily dosing and a favorable metabolic profile. Its primary side effect is elevated bilirubin, rarely necessitating treatment cessation.
Area of Science:
- Pharmacology
- Virology
- Drug Development
Context:
- Human Immunodeficiency Virus (HIV) protease inhibitors are crucial in antiretroviral therapy.
- Understanding the comparative advantages and disadvantages of different protease inhibitors is essential for optimizing treatment regimens.
Purpose:
- To evaluate the pharmacological profile and clinical characteristics of Atazanavir.
- To compare Atazanavir with other protease inhibitors regarding efficacy, safety, and patient compliance.
Summary:
- Atazanavir functions as an HIV protease inhibitor with advantages including once-daily dosing, reduced capsule burden, and fewer gastrointestinal issues.
- It exhibits a favorable metabolic profile, particularly concerning carbohydrate metabolism.
- The main adverse effect is secondary hyperbilirubinemia, leading to jaundice, which infrequently requires drug discontinuation. Other adverse events like nephrolithiasis and ECG alterations are exceptionally rare.
Impact:
- Atazanavir presents a viable treatment option within HIV management, potentially improving patient adherence and quality of life.
- Its distinct side effect profile, especially the manageable hyperbilirubinemia, differentiates it from other protease inhibitors.
- Further research can explore long-term outcomes and its role in diverse patient populations.
Related Concept Videos
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...